The Global Atrial Fibrillation Market is projected to reach nearly USD 16.2 billion by 2020. Growing geriatric population and rising cases of brain damage, atrial fibrillation, and strokes caused by blood clots are factors that propel the industry. People suffering from atrial fibrillation (AF) are given blood thinning & anti-clotting medicines. Based on the level of severity, this cardiovascular condition is of three types, namely, paroxysmal, ... Read more
